Why is GPT Healthcare falling/rising?

As of 22-Aug, GPT Healthcare Ltd is currently priced at 157.60, reflecting a decrease of 1.9, or 1.19%. The stock has underperformed its sector today by 0.47% and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 1.87%, and its performance over the last month shows a drop of 6.52%. Despite a 5% increase in profits over the past year, the stock has generated a return of -18.57%, indicating poor long-term growth, particularly with net sales growing at an annual rate of only 13.80%. Additionally, the company has seen a decrease in institutional investor participation, which may contribute to the stock's downward pressure.
In the broader market context, the Sensex has increased by 0.88% over the past week, contrasting sharply with GPT Healthcare's decline. The stock's year-to-date performance shows a significant underperformance of -13.79% compared to the Sensex's gain of 4.05%. This consistent underperformance against the benchmark over the last three years, coupled with negative quarterly results and a decrease in institutional stakes, suggests a lack of confidence among investors. The overall sentiment surrounding the stock appears to be negative, influenced by its falling participation and poor growth prospects, which are further exacerbated by its inability to keep pace with the broader market trends.